Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) is now available.
WuXi AppTec Co., Ltd. has revised the terms of reference for its Strategy Committee under the Board of Directors to strengthen its strategic development and decision-making processes. The Strategy Committee is tasked with recommending medium-to-long-term development strategies, investment and financing decisions, and policies related to sustainable development, thereby enhancing the company’s governance and operational efficiency.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$133.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. operates in the pharmaceutical and biotechnology industry, offering a range of services that include drug discovery, development, and manufacturing. The company focuses on enhancing its core competitiveness and optimizing corporate governance to support its strategic development needs.
Average Trading Volume: 9,084,704
Technical Sentiment Signal: Buy
Current Market Cap: HK$323.9B
For an in-depth examination of 2359 stock, go to TipRanks’ Overview page.